Institutional Ownership Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB). We have compiled data on the 26 institutions that hold shares in the stock, with a total of 922,981 shares, which have been reported (via 13F filing form) to have a value of $1.46 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
K2 Principal Fund, L.P.
Toronto, A6 |
Nov 15, 2024 Q3 2024 |
209,266
shares
|
$330,640
0.19% of portfolio
|
Q3 2024
Reduced 36.1%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
192,387
shares
|
$303,971
0.0% of portfolio
|
Q2 2024
Added 10.19%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
164,736
shares
|
$260,282
0.0% of portfolio
|
Q4 2024
Reduced 2.06%
|
|
|
Ayrton Capital LLC
Westport, CT |
Nov 13, 2023 Q3 2023 |
92,087
shares
|
$145,497
7.31% of portfolio
|
Q3 2023
Reduced 66.75%
|
|
|
Equitec Proprietary Markets, LLC
|
Jan 29, 2025 Q4 2024 |
82,727
shares
|
$130,708
0.07% of portfolio
|
Q3 2023
Added 34.7%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
49,300
shares
|
$77,894
0.0% of portfolio
|
Q4 2024
Reduced 0.8%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
35,228
shares
|
$55,660
0.0% of portfolio
|
Q3 2024
Reduced 35.76%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
26,841
shares
|
$42,408
0.0% of portfolio
|
Q4 2024
Reduced 2.75%
|
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
25,900
shares
|
$40,922
0.0% of portfolio
|
Q3 2024
Added 9.28%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
19,208
shares
|
$30,348
0.0% of portfolio
|
Q2 2024
Reduced 0.11%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
13,346
shares
|
$21,086
0.0% of portfolio
|
Q2 2024
Reduced 36.76%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
8,354
shares
|
$13,199
0.0% of portfolio
|
Q3 2024
Reduced 69.7%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Feb 13, 2025 Q4 2024 |
2,445
shares
|
$3,863
0.0% of portfolio
|
Q4 2024
Reduced 14.51%
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Feb 07, 2025 Q4 2024 |
508
shares
|
$802
0.0% of portfolio
|
Q3 2024
Reduced 0.97%
|
|
|
Covestor LTD
Boston, MA |
Feb 13, 2025 Q4 2024 |
275
shares
|
$434
0.0% of portfolio
|
Q4 2024
Added 21.68%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
117
shares
|
$184
0.0% of portfolio
|
Q3 2024
Reduced 23.03%
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2024 Q3 2024 |
100
shares
|
$158
0.0% of portfolio
|
Q3 2024
Reduced 61.69%
|
|
|
Planning Capital Management Corp
Paoli, PA |
Nov 06, 2024 Q3 2024 |
100
shares
|
$158
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
18
shares
|
$28
0.0% of portfolio
|
Q3 2024
Reduced 5.26%
|
|
|
Highlander Capital Management, LLC
Short Hills, NJ |
May 20, 2024 Q1 2024 |
14
shares
|
$22
0.0% of portfolio
|
Q3 2023
New holding
|
|
|
Sachetta, LLC
Lynnfield, MA |
Jan 21, 2025 Q4 2024 |
14
shares
|
$22
0.0% of portfolio
|
Q4 2023
New holding
|
|
|
Bfsg, LLC
|
Jan 31, 2025 Q4 2024 |
5
shares
|
$7
0.0% of portfolio
|
Q2 2024
Reduced 28.57%
|
|
|
New Edge Advisors, LLC
New Orleans, LA |
Feb 13, 2025 Q4 2024 |
2
shares
|
$3
0.0% of portfolio
|
Q2 2024
Reduced 33.33%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
2
shares
|
$3
0.0% of portfolio
|
Q3 2024
Reduced 33.33%
|
|
|
Cwm, LLC
|
Feb 04, 2025 Q4 2024 |
1
shares
|
$1
0.0% of portfolio
|
Q2 2024
Reduced 99.9%
|